nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Eosinophilia—Leflunomide—rheumatoid arthritis	0.00656	0.00656	CcSEcCtD
Oritavancin—Infestation—Azathioprine—rheumatoid arthritis	0.00626	0.00626	CcSEcCtD
Oritavancin—Infestation NOS—Azathioprine—rheumatoid arthritis	0.00626	0.00626	CcSEcCtD
Oritavancin—Urticaria—Penicillamine—rheumatoid arthritis	0.00609	0.00609	CcSEcCtD
Oritavancin—Hypoglycaemia—Cyclosporine—rheumatoid arthritis	0.00606	0.00606	CcSEcCtD
Oritavancin—Nausea—Ergocalciferol—rheumatoid arthritis	0.00605	0.00605	CcSEcCtD
Oritavancin—Infestation NOS—Leflunomide—rheumatoid arthritis	0.00591	0.00591	CcSEcCtD
Oritavancin—Infestation—Leflunomide—rheumatoid arthritis	0.00591	0.00591	CcSEcCtD
Oritavancin—Pruritus—Auranofin—rheumatoid arthritis	0.00587	0.00587	CcSEcCtD
Oritavancin—Abscess—Methotrexate—rheumatoid arthritis	0.0057	0.0057	CcSEcCtD
Oritavancin—Diarrhoea—Auranofin—rheumatoid arthritis	0.00568	0.00568	CcSEcCtD
Oritavancin—Hypersensitivity—Penicillamine—rheumatoid arthritis	0.00565	0.00565	CcSEcCtD
Oritavancin—Erythema multiforme—Azathioprine—rheumatoid arthritis	0.00531	0.00531	CcSEcCtD
Oritavancin—Vomiting—Auranofin—rheumatoid arthritis	0.00528	0.00528	CcSEcCtD
Oritavancin—Diarrhoea—Penicillamine—rheumatoid arthritis	0.00525	0.00525	CcSEcCtD
Oritavancin—Rash—Auranofin—rheumatoid arthritis	0.00523	0.00523	CcSEcCtD
Oritavancin—Dermatitis—Auranofin—rheumatoid arthritis	0.00523	0.00523	CcSEcCtD
Oritavancin—Oedema peripheral—Leflunomide—rheumatoid arthritis	0.00523	0.00523	CcSEcCtD
Oritavancin—Connective tissue disorder—Leflunomide—rheumatoid arthritis	0.00521	0.00521	CcSEcCtD
Oritavancin—Extravasation—Methotrexate—rheumatoid arthritis	0.00516	0.00516	CcSEcCtD
Oritavancin—Immune system disorder—Azathioprine—rheumatoid arthritis	0.00507	0.00507	CcSEcCtD
Oritavancin—Mediastinal disorder—Azathioprine—rheumatoid arthritis	0.00506	0.00506	CcSEcCtD
Oritavancin—Bronchospasm—Cyclosporine—rheumatoid arthritis	0.00503	0.00503	CcSEcCtD
Oritavancin—Erythema multiforme—Leflunomide—rheumatoid arthritis	0.00502	0.00502	CcSEcCtD
Oritavancin—Nausea—Auranofin—rheumatoid arthritis	0.00493	0.00493	CcSEcCtD
Oritavancin—Cardiac disorder—Leflunomide—rheumatoid arthritis	0.00492	0.00492	CcSEcCtD
Oritavancin—Vomiting—Penicillamine—rheumatoid arthritis	0.00488	0.00488	CcSEcCtD
Oritavancin—Hyperuricaemia—Methotrexate—rheumatoid arthritis	0.00486	0.00486	CcSEcCtD
Oritavancin—Rash—Penicillamine—rheumatoid arthritis	0.00483	0.00483	CcSEcCtD
Oritavancin—Dermatitis—Penicillamine—rheumatoid arthritis	0.00483	0.00483	CcSEcCtD
Oritavancin—Immune system disorder—Leflunomide—rheumatoid arthritis	0.00479	0.00479	CcSEcCtD
Oritavancin—Mediastinal disorder—Leflunomide—rheumatoid arthritis	0.00478	0.00478	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Hydrocortisone—rheumatoid arthritis	0.00464	0.00464	CcSEcCtD
Oritavancin—Malnutrition—Leflunomide—rheumatoid arthritis	0.00462	0.00462	CcSEcCtD
Oritavancin—Blood uric acid increased—Methotrexate—rheumatoid arthritis	0.00459	0.00459	CcSEcCtD
Oritavancin—Infestation NOS—Cyclosporine—rheumatoid arthritis	0.00456	0.00456	CcSEcCtD
Oritavancin—Infestation—Cyclosporine—rheumatoid arthritis	0.00456	0.00456	CcSEcCtD
Oritavancin—Nausea—Penicillamine—rheumatoid arthritis	0.00455	0.00455	CcSEcCtD
Oritavancin—Anaemia—Azathioprine—rheumatoid arthritis	0.00452	0.00452	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Methylprednisolone—rheumatoid arthritis	0.00436	0.00436	CcSEcCtD
Oritavancin—Anaemia—Leflunomide—rheumatoid arthritis	0.00427	0.00427	CcSEcCtD
Oritavancin—Angioedema—Leflunomide—rheumatoid arthritis	0.00422	0.00422	CcSEcCtD
Oritavancin—Bronchospasm—Methylprednisolone—rheumatoid arthritis	0.0042	0.0042	CcSEcCtD
Oritavancin—Myalgia—Azathioprine—rheumatoid arthritis	0.00416	0.00416	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.00414	0.00414	CcSEcCtD
Oritavancin—Infestation—Hydrocortisone—rheumatoid arthritis	0.00405	0.00405	CcSEcCtD
Oritavancin—Infestation NOS—Hydrocortisone—rheumatoid arthritis	0.00405	0.00405	CcSEcCtD
Oritavancin—Connective tissue disorder—Cyclosporine—rheumatoid arthritis	0.00402	0.00402	CcSEcCtD
Oritavancin—Infection—Azathioprine—rheumatoid arthritis	0.00397	0.00397	CcSEcCtD
Oritavancin—Myalgia—Leflunomide—rheumatoid arthritis	0.00393	0.00393	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.00391	0.00391	CcSEcCtD
Oritavancin—Skin disorder—Azathioprine—rheumatoid arthritis	0.00388	0.00388	CcSEcCtD
Oritavancin—Infestation NOS—Methylprednisolone—rheumatoid arthritis	0.00381	0.00381	CcSEcCtD
Oritavancin—Infestation—Methylprednisolone—rheumatoid arthritis	0.00381	0.00381	CcSEcCtD
Oritavancin—Infection—Leflunomide—rheumatoid arthritis	0.00374	0.00374	CcSEcCtD
Oritavancin—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.0037	0.0037	CcSEcCtD
Oritavancin—Mediastinal disorder—Cyclosporine—rheumatoid arthritis	0.00369	0.00369	CcSEcCtD
Oritavancin—Tachycardia—Leflunomide—rheumatoid arthritis	0.00368	0.00368	CcSEcCtD
Oritavancin—Skin disorder—Leflunomide—rheumatoid arthritis	0.00366	0.00366	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Azathioprine—rheumatoid arthritis	0.00364	0.00364	CcSEcCtD
Oritavancin—Connective tissue disorder—Hydrocortisone—rheumatoid arthritis	0.00358	0.00358	CcSEcCtD
Oritavancin—Malnutrition—Cyclosporine—rheumatoid arthritis	0.00356	0.00356	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Prednisone—rheumatoid arthritis	0.00345	0.00345	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.00345	0.00345	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Leflunomide—rheumatoid arthritis	0.00343	0.00343	CcSEcCtD
Oritavancin—Connective tissue disorder—Methylprednisolone—rheumatoid arthritis	0.00336	0.00336	CcSEcCtD
Oritavancin—Anaemia—Cyclosporine—rheumatoid arthritis	0.00329	0.00329	CcSEcCtD
Oritavancin—Immune system disorder—Hydrocortisone—rheumatoid arthritis	0.00329	0.00329	CcSEcCtD
Oritavancin—Angioedema—Cyclosporine—rheumatoid arthritis	0.00326	0.00326	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.00325	0.00325	CcSEcCtD
Oritavancin—Cardiac disorder—Methylprednisolone—rheumatoid arthritis	0.00317	0.00317	CcSEcCtD
Oritavancin—Malnutrition—Hydrocortisone—rheumatoid arthritis	0.00317	0.00317	CcSEcCtD
Oritavancin—Immune system disorder—Methylprednisolone—rheumatoid arthritis	0.00309	0.00309	CcSEcCtD
Oritavancin—Mediastinal disorder—Methylprednisolone—rheumatoid arthritis	0.00308	0.00308	CcSEcCtD
Oritavancin—Myalgia—Cyclosporine—rheumatoid arthritis	0.00303	0.00303	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.00301	0.00301	CcSEcCtD
Oritavancin—Urticaria—Leflunomide—rheumatoid arthritis	0.00299	0.00299	CcSEcCtD
Oritavancin—Malnutrition—Methylprednisolone—rheumatoid arthritis	0.00298	0.00298	CcSEcCtD
Oritavancin—Angioedema—Prednisolone—rheumatoid arthritis	0.00296	0.00296	CcSEcCtD
Oritavancin—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.00294	0.00294	CcSEcCtD
Oritavancin—Angioedema—Hydrocortisone—rheumatoid arthritis	0.00289	0.00289	CcSEcCtD
Oritavancin—Infection—Cyclosporine—rheumatoid arthritis	0.00289	0.00289	CcSEcCtD
Oritavancin—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.00285	0.00285	CcSEcCtD
Oritavancin—Skin disorder—Cyclosporine—rheumatoid arthritis	0.00283	0.00283	CcSEcCtD
Oritavancin—Eosinophilia—Methotrexate—rheumatoid arthritis	0.0028	0.0028	CcSEcCtD
Oritavancin—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.00278	0.00278	CcSEcCtD
Oritavancin—Diarrhoea—Azathioprine—rheumatoid arthritis	0.00273	0.00273	CcSEcCtD
Oritavancin—Angioedema—Triamcinolone—rheumatoid arthritis	0.00273	0.00273	CcSEcCtD
Oritavancin—Angioedema—Methylprednisolone—rheumatoid arthritis	0.00272	0.00272	CcSEcCtD
Oritavancin—Myalgia—Hydrocortisone—rheumatoid arthritis	0.0027	0.0027	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.00268	0.00268	CcSEcCtD
Oritavancin—Pruritus—Leflunomide—rheumatoid arthritis	0.00267	0.00267	CcSEcCtD
Oritavancin—Connective tissue disorder—Prednisone—rheumatoid arthritis	0.00266	0.00266	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.00265	0.00265	CcSEcCtD
Oritavancin—Dizziness—Azathioprine—rheumatoid arthritis	0.00264	0.00264	CcSEcCtD
Oritavancin—Tachycardia—Prednisolone—rheumatoid arthritis	0.00258	0.00258	CcSEcCtD
Oritavancin—Diarrhoea—Leflunomide—rheumatoid arthritis	0.00258	0.00258	CcSEcCtD
Oritavancin—Infection—Hydrocortisone—rheumatoid arthritis	0.00257	0.00257	CcSEcCtD
Oritavancin—Myalgia—Triamcinolone—rheumatoid arthritis	0.00254	0.00254	CcSEcCtD
Oritavancin—Vomiting—Azathioprine—rheumatoid arthritis	0.00254	0.00254	CcSEcCtD
Oritavancin—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.00254	0.00254	CcSEcCtD
Oritavancin—Myalgia—Methylprednisolone—rheumatoid arthritis	0.00253	0.00253	CcSEcCtD
Oritavancin—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.00252	0.00252	CcSEcCtD
Oritavancin—Infestation NOS—Methotrexate—rheumatoid arthritis	0.00252	0.00252	CcSEcCtD
Oritavancin—Infestation—Methotrexate—rheumatoid arthritis	0.00252	0.00252	CcSEcCtD
Oritavancin—Rash—Azathioprine—rheumatoid arthritis	0.00252	0.00252	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.00252	0.00252	CcSEcCtD
Oritavancin—Dermatitis—Azathioprine—rheumatoid arthritis	0.00251	0.00251	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.00251	0.00251	CcSEcCtD
Oritavancin—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.00251	0.00251	CcSEcCtD
Oritavancin—Headache—Azathioprine—rheumatoid arthritis	0.0025	0.0025	CcSEcCtD
Oritavancin—Dizziness—Leflunomide—rheumatoid arthritis	0.00249	0.00249	CcSEcCtD
Oritavancin—Angioedema—Dexamethasone—rheumatoid arthritis	0.00247	0.00247	CcSEcCtD
Oritavancin—Angioedema—Betamethasone—rheumatoid arthritis	0.00247	0.00247	CcSEcCtD
Oritavancin—Immune system disorder—Prednisone—rheumatoid arthritis	0.00245	0.00245	CcSEcCtD
Oritavancin—Infection—Triamcinolone—rheumatoid arthritis	0.00242	0.00242	CcSEcCtD
Oritavancin—Infection—Methylprednisolone—rheumatoid arthritis	0.00241	0.00241	CcSEcCtD
Oritavancin—Vomiting—Leflunomide—rheumatoid arthritis	0.0024	0.0024	CcSEcCtD
Oritavancin—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.00238	0.00238	CcSEcCtD
Oritavancin—Rash—Leflunomide—rheumatoid arthritis	0.00238	0.00238	CcSEcCtD
Oritavancin—Tachycardia—Triamcinolone—rheumatoid arthritis	0.00238	0.00238	CcSEcCtD
Oritavancin—Dermatitis—Leflunomide—rheumatoid arthritis	0.00237	0.00237	CcSEcCtD
Oritavancin—Nausea—Azathioprine—rheumatoid arthritis	0.00237	0.00237	CcSEcCtD
Oritavancin—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.00237	0.00237	CcSEcCtD
Oritavancin—Headache—Leflunomide—rheumatoid arthritis	0.00236	0.00236	CcSEcCtD
Oritavancin—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.00236	0.00236	CcSEcCtD
Oritavancin—Malnutrition—Prednisone—rheumatoid arthritis	0.00236	0.00236	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.00236	0.00236	CcSEcCtD
Oritavancin—Urticaria—Cyclosporine—rheumatoid arthritis	0.00231	0.00231	CcSEcCtD
Oritavancin—Myalgia—Dexamethasone—rheumatoid arthritis	0.0023	0.0023	CcSEcCtD
Oritavancin—Myalgia—Betamethasone—rheumatoid arthritis	0.0023	0.0023	CcSEcCtD
Oritavancin—Nausea—Leflunomide—rheumatoid arthritis	0.00224	0.00224	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.00223	0.00223	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.00222	0.00222	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.00221	0.00221	CcSEcCtD
Oritavancin—Infection—Dexamethasone—rheumatoid arthritis	0.00219	0.00219	CcSEcCtD
Oritavancin—Infection—Betamethasone—rheumatoid arthritis	0.00219	0.00219	CcSEcCtD
Oritavancin—Anaemia—Prednisone—rheumatoid arthritis	0.00218	0.00218	CcSEcCtD
Oritavancin—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.00217	0.00217	CcSEcCtD
Oritavancin—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.00217	0.00217	CcSEcCtD
Oritavancin—Tachycardia—Dexamethasone—rheumatoid arthritis	0.00216	0.00216	CcSEcCtD
Oritavancin—Tachycardia—Betamethasone—rheumatoid arthritis	0.00216	0.00216	CcSEcCtD
Oritavancin—Angioedema—Prednisone—rheumatoid arthritis	0.00215	0.00215	CcSEcCtD
Oritavancin—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00214	0.00214	CcSEcCtD
Oritavancin—Erythema multiforme—Methotrexate—rheumatoid arthritis	0.00214	0.00214	CcSEcCtD
Oritavancin—Urticaria—Prednisolone—rheumatoid arthritis	0.0021	0.0021	CcSEcCtD
Oritavancin—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.0021	0.0021	CcSEcCtD
Oritavancin—Pruritus—Cyclosporine—rheumatoid arthritis	0.00206	0.00206	CcSEcCtD
Oritavancin—Urticaria—Hydrocortisone—rheumatoid arthritis	0.00205	0.00205	CcSEcCtD
Oritavancin—Immune system disorder—Methotrexate—rheumatoid arthritis	0.00204	0.00204	CcSEcCtD
Oritavancin—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.00204	0.00204	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.00201	0.00201	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.00201	0.00201	CcSEcCtD
Oritavancin—Myalgia—Prednisone—rheumatoid arthritis	0.00201	0.00201	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.00199	0.00199	CcSEcCtD
Oritavancin—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00199	0.00199	CcSEcCtD
Oritavancin—Malnutrition—Methotrexate—rheumatoid arthritis	0.00197	0.00197	CcSEcCtD
Oritavancin—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.00195	0.00195	CcSEcCtD
Oritavancin—Urticaria—Triamcinolone—rheumatoid arthritis	0.00193	0.00193	CcSEcCtD
Oritavancin—Urticaria—Methylprednisolone—rheumatoid arthritis	0.00193	0.00193	CcSEcCtD
Oritavancin—Dizziness—Cyclosporine—rheumatoid arthritis	0.00192	0.00192	CcSEcCtD
Oritavancin—Infection—Prednisone—rheumatoid arthritis	0.00191	0.00191	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.00191	0.00191	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.00191	0.00191	CcSEcCtD
Oritavancin—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.0019	0.0019	CcSEcCtD
Oritavancin—Nervous system disorder—Prednisone—rheumatoid arthritis	0.00189	0.00189	CcSEcCtD
Oritavancin—Tachycardia—Prednisone—rheumatoid arthritis	0.00188	0.00188	CcSEcCtD
Oritavancin—Skin disorder—Prednisone—rheumatoid arthritis	0.00187	0.00187	CcSEcCtD
Oritavancin—Vomiting—Cyclosporine—rheumatoid arthritis	0.00185	0.00185	CcSEcCtD
Oritavancin—Rash—Cyclosporine—rheumatoid arthritis	0.00183	0.00183	CcSEcCtD
Oritavancin—Dermatitis—Cyclosporine—rheumatoid arthritis	0.00183	0.00183	CcSEcCtD
Oritavancin—Pruritus—Hydrocortisone—rheumatoid arthritis	0.00183	0.00183	CcSEcCtD
Oritavancin—Headache—Cyclosporine—rheumatoid arthritis	0.00182	0.00182	CcSEcCtD
Oritavancin—Anaemia—Methotrexate—rheumatoid arthritis	0.00182	0.00182	CcSEcCtD
Oritavancin—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.00179	0.00179	CcSEcCtD
Oritavancin—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.00179	0.00179	CcSEcCtD
Oritavancin—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.00177	0.00177	CcSEcCtD
Oritavancin—Urticaria—Dexamethasone—rheumatoid arthritis	0.00175	0.00175	CcSEcCtD
Oritavancin—Urticaria—Betamethasone—rheumatoid arthritis	0.00175	0.00175	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.00175	0.00175	CcSEcCtD
Oritavancin—Dizziness—Prednisolone—rheumatoid arthritis	0.00175	0.00175	CcSEcCtD
Oritavancin—Nausea—Cyclosporine—rheumatoid arthritis	0.00173	0.00173	CcSEcCtD
Oritavancin—Pruritus—Triamcinolone—rheumatoid arthritis	0.00172	0.00172	CcSEcCtD
Oritavancin—Pruritus—Methylprednisolone—rheumatoid arthritis	0.00172	0.00172	CcSEcCtD
Oritavancin—Dizziness—Hydrocortisone—rheumatoid arthritis	0.00171	0.00171	CcSEcCtD
Oritavancin—Myalgia—Methotrexate—rheumatoid arthritis	0.00168	0.00168	CcSEcCtD
Oritavancin—Rash—Prednisolone—rheumatoid arthritis	0.00167	0.00167	CcSEcCtD
Oritavancin—Dermatitis—Prednisolone—rheumatoid arthritis	0.00167	0.00167	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.00167	0.00167	CcSEcCtD
Oritavancin—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.00166	0.00166	CcSEcCtD
Oritavancin—Headache—Prednisolone—rheumatoid arthritis	0.00166	0.00166	CcSEcCtD
Oritavancin—Vomiting—Hydrocortisone—rheumatoid arthritis	0.00164	0.00164	CcSEcCtD
Oritavancin—Rash—Hydrocortisone—rheumatoid arthritis	0.00163	0.00163	CcSEcCtD
Oritavancin—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.00163	0.00163	CcSEcCtD
Oritavancin—Headache—Hydrocortisone—rheumatoid arthritis	0.00162	0.00162	CcSEcCtD
Oritavancin—Dizziness—Triamcinolone—rheumatoid arthritis	0.00161	0.00161	CcSEcCtD
Oritavancin—Dizziness—Methylprednisolone—rheumatoid arthritis	0.00161	0.00161	CcSEcCtD
Oritavancin—Infection—Methotrexate—rheumatoid arthritis	0.0016	0.0016	CcSEcCtD
Oritavancin—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.00158	0.00158	CcSEcCtD
Oritavancin—Nausea—Prednisolone—rheumatoid arthritis	0.00157	0.00157	CcSEcCtD
Oritavancin—Pruritus—Dexamethasone—rheumatoid arthritis	0.00156	0.00156	CcSEcCtD
Oritavancin—Pruritus—Betamethasone—rheumatoid arthritis	0.00156	0.00156	CcSEcCtD
Oritavancin—Skin disorder—Methotrexate—rheumatoid arthritis	0.00156	0.00156	CcSEcCtD
Oritavancin—Vomiting—Triamcinolone—rheumatoid arthritis	0.00155	0.00155	CcSEcCtD
Oritavancin—Vomiting—Methylprednisolone—rheumatoid arthritis	0.00154	0.00154	CcSEcCtD
Oritavancin—Nausea—Hydrocortisone—rheumatoid arthritis	0.00154	0.00154	CcSEcCtD
Oritavancin—Rash—Triamcinolone—rheumatoid arthritis	0.00153	0.00153	CcSEcCtD
Oritavancin—Dermatitis—Triamcinolone—rheumatoid arthritis	0.00153	0.00153	CcSEcCtD
Oritavancin—Rash—Methylprednisolone—rheumatoid arthritis	0.00153	0.00153	CcSEcCtD
Oritavancin—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.00153	0.00153	CcSEcCtD
Oritavancin—Urticaria—Prednisone—rheumatoid arthritis	0.00153	0.00153	CcSEcCtD
Oritavancin—Headache—Triamcinolone—rheumatoid arthritis	0.00153	0.00153	CcSEcCtD
Oritavancin—Headache—Methylprednisolone—rheumatoid arthritis	0.00152	0.00152	CcSEcCtD
Oritavancin—Diarrhoea—Betamethasone—rheumatoid arthritis	0.00151	0.00151	CcSEcCtD
Oritavancin—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.00151	0.00151	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.00146	0.00146	CcSEcCtD
Oritavancin—Dizziness—Betamethasone—rheumatoid arthritis	0.00146	0.00146	CcSEcCtD
Oritavancin—Dizziness—Dexamethasone—rheumatoid arthritis	0.00146	0.00146	CcSEcCtD
Oritavancin—Nausea—Triamcinolone—rheumatoid arthritis	0.00145	0.00145	CcSEcCtD
Oritavancin—Nausea—Methylprednisolone—rheumatoid arthritis	0.00144	0.00144	CcSEcCtD
Oritavancin—Hypersensitivity—Prednisone—rheumatoid arthritis	0.00142	0.00142	CcSEcCtD
Oritavancin—Vomiting—Dexamethasone—rheumatoid arthritis	0.0014	0.0014	CcSEcCtD
Oritavancin—Vomiting—Betamethasone—rheumatoid arthritis	0.0014	0.0014	CcSEcCtD
Oritavancin—Rash—Betamethasone—rheumatoid arthritis	0.00139	0.00139	CcSEcCtD
Oritavancin—Rash—Dexamethasone—rheumatoid arthritis	0.00139	0.00139	CcSEcCtD
Oritavancin—Dermatitis—Betamethasone—rheumatoid arthritis	0.00139	0.00139	CcSEcCtD
Oritavancin—Dermatitis—Dexamethasone—rheumatoid arthritis	0.00139	0.00139	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.00139	0.00139	CcSEcCtD
Oritavancin—Headache—Betamethasone—rheumatoid arthritis	0.00138	0.00138	CcSEcCtD
Oritavancin—Headache—Dexamethasone—rheumatoid arthritis	0.00138	0.00138	CcSEcCtD
Oritavancin—Pruritus—Prednisone—rheumatoid arthritis	0.00136	0.00136	CcSEcCtD
Oritavancin—Diarrhoea—Prednisone—rheumatoid arthritis	0.00132	0.00132	CcSEcCtD
Oritavancin—Nausea—Dexamethasone—rheumatoid arthritis	0.00131	0.00131	CcSEcCtD
Oritavancin—Nausea—Betamethasone—rheumatoid arthritis	0.00131	0.00131	CcSEcCtD
Oritavancin—Urticaria—Methotrexate—rheumatoid arthritis	0.00128	0.00128	CcSEcCtD
Oritavancin—Dizziness—Prednisone—rheumatoid arthritis	0.00127	0.00127	CcSEcCtD
Oritavancin—Vomiting—Prednisone—rheumatoid arthritis	0.00122	0.00122	CcSEcCtD
Oritavancin—Rash—Prednisone—rheumatoid arthritis	0.00121	0.00121	CcSEcCtD
Oritavancin—Dermatitis—Prednisone—rheumatoid arthritis	0.00121	0.00121	CcSEcCtD
Oritavancin—Headache—Prednisone—rheumatoid arthritis	0.00121	0.00121	CcSEcCtD
Oritavancin—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.00118	0.00118	CcSEcCtD
Oritavancin—Nausea—Prednisone—rheumatoid arthritis	0.00114	0.00114	CcSEcCtD
Oritavancin—Pruritus—Methotrexate—rheumatoid arthritis	0.00114	0.00114	CcSEcCtD
Oritavancin—Diarrhoea—Methotrexate—rheumatoid arthritis	0.0011	0.0011	CcSEcCtD
Oritavancin—Dizziness—Methotrexate—rheumatoid arthritis	0.00106	0.00106	CcSEcCtD
Oritavancin—Vomiting—Methotrexate—rheumatoid arthritis	0.00102	0.00102	CcSEcCtD
Oritavancin—Rash—Methotrexate—rheumatoid arthritis	0.00101	0.00101	CcSEcCtD
Oritavancin—Dermatitis—Methotrexate—rheumatoid arthritis	0.00101	0.00101	CcSEcCtD
Oritavancin—Headache—Methotrexate—rheumatoid arthritis	0.00101	0.00101	CcSEcCtD
Oritavancin—Nausea—Methotrexate—rheumatoid arthritis	0.000955	0.000955	CcSEcCtD
